Qualità affidabile, risultati visibili
Hairgenetix è orgogliosa di offrire soluzioni all'avanguardia per la crescita dei capelli che non sono solo efficaci, ma anche costruite sulla completa trasparenza.
Per colpire la caduta dei capelli con precisione
Hairgenetix si dedica a rivoluzionare la cura e la crescita dei capelli attraverso innovazioni all'avanguardia. Il nostro team di scienziati ed esperti è impegnato nello sviluppo di soluzioni efficaci per la perdita e il diradamento dei capelli, con la missione di fare davvero la differenza nella vita di chi ne è colpito.
Tutto inizia con la comprensione della scienza alla base della caduta dei capelli. Poi uniamo i più recenti sviluppi della tecnologia e della scienza per sviluppare soluzioni innovative che utilizzino il potere della natura, invece di lavorare contro di essa.
Il ciclo di crescita dei capelli
Una chiara comprensione dell'intero ciclo di crescita dei capelli non solo aiuta ad affrontare i problemi più comuni, ma distingue anche tra ciò che è tipico e ciò che può richiedere attenzione. Conoscendo la scienza che sta alla base della perdita e della ricrescita dei capelli, possiamo identificare e prevenire meglio i fattori che possono interrompere questo ciclo naturale. La conoscenza è potere e con essa possiamo adottare misure proattive per proteggere e nutrire il ritmo naturale dei capelli.
Microiniezioni per la massima efficacia
La mesoterapia offre un approccio superiore alla cura dei capelli rispetto ai tradizionali sieri topici e ai derma roller. Utilizzando microiniezioni, garantisce un'infusione precisa del siero per la crescita dei capelli direttamente nel cuoio capelluto, mirando e nutrendo i capelli alla radice per la massima efficacia.
La cartuccia di siero brevettata, dotata di 12 microaghi, eroga il siero avanzato per la crescita dei capelli direttamente nel cuoio capelluto con eccezionale precisione. Progettato per un assorbimento ottimale e per migliorare i risultati di crescita dei capelli, il sistema è dotato di scarico del fluido e profondità dell'ago regolabili, che consentono un'esperienza di trattamento personalizzata che soddisfa le esigenze individuali.
Stimolazione a microcorrente EMS
La penna mesoterapica Hairgenetix utilizza anche la più recente tecnologia innovativa EMS. La microcorrente circolare multipolare di livello 4 raggiunge la pelle in profondità e stimola le cellule dei capelli e della pelle, accelerando la sintesi del collagene. Questo amplifica e potenzia l'effetto del siero avanzato per la crescita dei capelli.
The Science Behind Our Ingredients
Understanding the active compounds that power Hairgenetix hair growth solutions
How copper peptides promote hair growth
Copper peptides are short chains of amino acids bound to a copper ion. The two most researched for hair growth are GHK-Cu and AHK-Cu. They work through three mechanisms:
Angiogenesis — stimulates new blood vessel formation around follicles, increasing oxygen and nutrient delivery.
Anti-inflammation — reduces pro-inflammatory cytokines (TNF-α, IL-6), protecting follicles from chronic inflammation.
Extended growth phase — activates Wnt/β-catenin pathways, extending the anagen phase and delaying regression.
A 2012 review documented GHK-Cu's ability to increase hair follicle size by up to 40%
Pickart, Vasquez-Soltero, and Margolina confirmed that copper peptides reactivate dormant follicles in both men and women, promoting angiogenesis and reducing scalp inflammation at the cellular level.
PDRN activates the adenosine A2A receptor for tissue regeneration
Clinical studies show significant improvements in tissue quality within 4–8 weeks of PDRN treatment. By promoting angiogenesis alongside copper peptides, PDRN amplifies nutrient delivery to the hair follicle.
What is PDRN and why is it in Hairgenetix?
PDRN (Polydeoxyribonucleotide) is a bioactive compound extracted from salmon DNA. It triggers three key responses in the scalp:
Tissue regeneration — promotes fibroblast proliferation and collagen synthesis, rebuilding the extracellular matrix that anchors follicles.
Scalp healing — accelerates repair of micro-damage caused by inflammation, oxidative stress, or microneedling.
Enhanced blood flow — promotes angiogenesis alongside copper peptides, amplifying nutrient delivery to follicles.
Clinical Evidence
Results from the Hairgenetix 150-day clinical trial and published peer-reviewed research
The Hairgenetix clinical trial
In a 150-day clinical trial involving 30 men and women aged 18–65 with various types of hair loss, the Hairgenetix serum achieved:
93% reduction in hair shedding (pull test)
75% of participants reported visible new growth by day 90
70% improvement in hair density (trichoscopy)
90% satisfaction rate at trial completion
All participants used the Meso-Infusion System as directed, with assessments at 30, 60, 90, 120, and 150 days under medical supervision.
Published research supporting hair mesotherapy
Pickart et al. (2012) — GHK-Cu increases follicle size, promotes angiogenesis, reactivates dormant follicles.
Dhurat et al. (2013) — Microneedling significantly improves hair count in androgenetic alopecia.
Mesotherapy Review (2023) — Systematic review confirms efficacy across multiple treatment protocols.
Copper Peptides & Hair (2019) — Copper peptides validated for stimulating hair follicle activity.
Xu et al. (2024) — Microneedling + active compounds shows superior results vs. topical-only.
How mesotherapy compares
Hair Mesotherapy (Hairgenetix) — Micro-infusion of copper peptides + PDRN directly into scalp. At-home, ~€50/month. Results in 2–4 months.
Minoxidil — Topical vasodilator, €20–40/month. Must use indefinitely; scalp irritation common.
Finasteride — Oral DHT blocker, €30–60/month. Prescription only; hormonal side effects.
Alternative treatments
PRP Therapy — Platelet-rich plasma injections, €200–500/session. Clinic only; expensive with mixed evidence.
Low-Level Laser (LLLT) — Red light stimulation, €200–800 device. Modest results; daily use required.
Hair Transplant — Surgical follicle relocation, €3,000–15,000. Invasive; limited donor hair.
Mesotherapy offers a middle ground — more targeted than topicals, less invasive than surgery, without hormonal side effects.
Frequently Asked Questions
Yes. The Hairgenetix system uses 24-karat gold micro-needles with controlled 1–2mm penetration depth, designed specifically for safe self-application. All serums are sterile, single-use vials. Follow the included instructions carefully.
Most users report reduced shedding within 4–6 weeks. Visible new growth typically appears between 2–4 months. In our clinical trial, 75% of participants saw visible improvement by day 90.
Many users combine mesotherapy with other treatments. Copper peptides work through different pathways than minoxidil (vasodilation) or finasteride (DHT blocking), so they can complement each other. Consult your doctor before combining treatments.
Our clinical trial included participants with androgenetic alopecia, telogen effluvium, and diffuse thinning. Results were positive across all types. However, mesotherapy cannot regrow hair where follicles are completely scarred (cicatricial alopecia).
The recommended protocol is once weekly for the first 3 months (intensive phase), then once every 2–4 weeks for maintenance. Each box contains 4 vials — a one-month supply during the intensive phase.
How Copper Peptide Treatment Compares
| Treatment | Evidence Level | Side Effects | Mechanism |
|---|---|---|---|
| GHK-Cu Copper Peptides | Moderate (peer-reviewed) | Minimal | Follicle regeneration via Wnt/β-catenin signalling |
| Minoxidil 5% | Strong (FDA approved) | Scalp irritation, initial shedding | Vasodilation, extends anagen phase |
| Finasteride 1mg | Strong (FDA approved) | Sexual side effects (1–2%) | DHT blocker (5α-reductase inhibitor) |
| PRP Therapy | Moderate (clinic-based) | Pain at injection site | Growth factor concentration |
Riferimenti
- Dhurat R et al. (2013). Randomized evaluator blinded study of effect of microneedling in androgenetic alopecia. Int J Trichology.
- Pickart L et al. (2012). The human tripeptide GHK-Cu in prevention of oxidative stress. Int J Mol Sci.
- Pei S et al. (2024). Microneedling for androgenetic alopecia: a systematic review and meta-analysis. J Cosmet Dermatol.
- Gupta AK et al. (2022). Microneedling for hair loss. J Cosmet Dermatol.
- Gupta AK et al. (2023). Systematic review of mesotherapy for hair loss. J Dermatolog Treat.
- PDRN polynucleotide gel efficacy for pattern hair loss. (2024). Arch Dermatol Res.
Scritto da Malcolm Smith, Founder of Hairgenetix · Revisionato medicalmente da Dr. Esther Bodde, Cosmetic & Medical Physician (MD) · Ultimo aggiornamento: marzo 2026
Riferimenti: Pickart et al. 2012 (GHK-Cu) · Mesotherapy Review 2023 · Copper Peptides & Hair 2019
